Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
331.60
+7.21 (+2.22%)
Streaming Delayed Price
Updated: 1:49 PM EDT, May 19, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
66
67
Next >
The Dividend Goldmine: 3 Shining Stocks With Growing Payouts
↗
April 19, 2024
Explore opportunities in the cable, restaurant and biotechnology sectors, revealing how dividend growth stocks are maximizing returns.
Via
InvestorPlace
Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick
↗
April 17, 2024
Amgen's Tezspire shows promising COPD trial results and potential market expansion beyond asthma. Comparison with Dupixent reveals significant benefits for eosinophil counts ≥150 cells/μL and ≥300...
Via
Benzinga
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
↗
April 17, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Coming FDA Approvals Could Send These 3 Drug Stocks Soaring
↗
April 17, 2024
When it comes to drug stocks, FDA approval can bring years or even decades of steady, high-margin revenue.
Via
InvestorPlace
Sell These 3 Blue-Chip Stocks Before the Next Earnings Stumble
↗
April 17, 2024
Though stocks that make the Dow 30 are often seen as solid investments, investors should consider these three blue chip stocks to sell.
Via
InvestorPlace
Topics
Stocks
Looking At Amgen's Recent Unusual Options Activity
↗
April 12, 2024
Via
Benzinga
Is Amgen Stock a Buy?
↗
April 11, 2024
Amgen's stock isn't expensive, but the business does face some challenges, which could have investors thinking twice.
Via
The Motley Fool
7 Analysts Have This To Say About Amgen
↗
April 03, 2024
Via
Benzinga
Can This High-Yield Dividend Stock Keep Beating the S&P 500?
↗
April 17, 2024
Amgen's shares have come under pressure this year, making it a compelling bargain buy.
Via
The Motley Fool
Topics
Stocks
Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever
↗
April 17, 2024
Not every business in operation today is built to thrive -- or even last -- indefinitely. These are.
Via
The Motley Fool
The 3 Best Biotech Stocks to Buy Now: Q2 Edition
↗
April 16, 2024
Investors can find some of the hottest, most explosive opportunities in these three top biotech stocks to buy now.
Via
InvestorPlace
3 Stocks to Buy Low Today With High Hopes for Tomorrow
↗
April 15, 2024
Amgen, Canadian Solar, and Diana Shipping are three undervalued stocks with high potential for growth that can enhance portfolio returns.
Via
InvestorPlace
Amgen, Shell And More On CNBC's 'Final Trades'
↗
April 15, 2024
On CNBC’s "Halftime Report Final Trades," Amy Raskin of Chevy Chase Trust said Shell plc (NYSE: SHEL) has 12% free
Via
Benzinga
Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?
↗
April 09, 2024
These seven companies were the top 2020 stocks. After their glory years have faded, they are looking to turn their fortunes around.
Via
InvestorPlace
Amgen Unusual Options Activity For April 02
↗
April 02, 2024
Via
Benzinga
Amgen Options Trading: A Deep Dive into Market Sentiment
↗
March 28, 2024
Via
Benzinga
3 High-Growth Biotech Stocks Investors Shouldn’t Sleep On in April
↗
April 09, 2024
These high-growth biotech stocks are certainly worth considering for investors looking for market-beating returns in the long-term.
Via
InvestorPlace
The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024
↗
April 07, 2024
Our economy is on the up and up, and investing is a must. Let's review the most undervalued S&P 500 stocks to buy in April.
Via
InvestorPlace
Topics
Economy
Stocks
2 Biotech Stocks to Buy Hand Over Fist in April
↗
April 06, 2024
These drugmakers have made important moves over the past year.
Via
The Motley Fool
3 Stocks to Consider Adding to Your Retirement Portfolio in April
↗
April 05, 2024
Use the recent short-term weakness from these powerhouse companies' stocks to your advantage.
Via
The Motley Fool
Topics
Retirement
Is Amgen The Rare Biotech With A Safe Dividend?
↗
April 03, 2024
Amgen pays a $2.25 per share quarterly dividend, which comes out to a 3.3% yield. Biotech can be notoriously volatile, though, so can investors count on receiving the same dividend quarter after...
Via
Talk Markets
Biotech Sector Nears Breakout: Will it Outperform in Q2?
April 03, 2024
The Biotech sector ETF is consolidating in its upper range, indicating a potential sector breakout despite modest year-to-date gains
Via
MarketBeat
Topics
ETFs
5 Healthcare Stocks to Buy for 2024
↗
April 02, 2024
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.
Via
InvestorPlace
Topics
Artificial Intelligence
Redditors Identify 'Best Undervalued Stocks' For 2024
↗
April 01, 2024
Savvy investors at Reddit discuss undervalued stocks for potential growth. Top picks include META, Google, Starbucks, Verizon, and others, with varied perspectives on their potential.
Via
Benzinga
Amgen's Diversified Portfolio To Drive Long-Term Growth, Though Uncertainties Loom, Analyst Says
↗
March 28, 2024
Raymond James resumes coverage of Amgen highlighting its diversified portfolio and strong presence across therapeutic areas for sustainable long-term growth. Innovative pipeline in oncology, rare...
Via
Benzinga
7 Stocks That Will Drive the Weight Loss Drugs Market
March 28, 2024
The booming weight loss drug market presents both lucrative potential and significant risks for investors seeking to capitalize on the global obesity crisis.
Via
MarketBeat
3 Biotech Stocks to Buy on the Dip: March 2024
↗
March 27, 2024
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three.
Via
InvestorPlace
7 Dow Stocks to Buy on the Dip: March 2024
↗
March 27, 2024
Analysts expect that the market may be heading toward a correction. These are seven of the best Dow stocks to buy when prices pull back.
Via
InvestorPlace
Topics
Stocks
Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
↗
March 25, 2024
Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom.
Via
InvestorPlace
Buffett’s Backdoor Buys: 3 Stocks His Secret Portfolio Is Quietly Accumulating
↗
March 25, 2024
Warren Buffett stocks and Berkshire Hathaway's portfolio of companies are hidden investment vehicles hiding in plain sight.
Via
InvestorPlace
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
66
67
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today